0001974158-24-000031.txt : 20240411 0001974158-24-000031.hdr.sgml : 20240411 20240411171516 ACCESSION NUMBER: 0001974158-24-000031 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Enliven Therapeutics, Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 24839276 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-647-8519 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: IMARA Inc. DATE OF NAME CHANGE: 20160419 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Heyman Richard A. CENTRAL INDEX KEY: 0001584759 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 144 1 primary_doc.xml 144 0001584759 XXXXXXXX LIVE 0001672619 Enliven Therapeutics, Inc. 001-39247 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519 Heyman Richard A. Director Common Jefferies LLC

520 Madison Ave 4th Fl New York NY 10022

649 12863.18 41000000 04/11/2024 Nasdaq Common 02/25/2020 Previous Purchase Enliven Therapeutics, Inc N 649 02/25/2020 N/A Y All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 07/17/2023, and all representations regarding material non-public information were made as of the adoption of the plan. 04/11/2024 07/17/2023 Richard T. Kuehnle